EGFR and nasopharyngeal carcinoma: EGFR overexpression was not associated with the DMFS of nasopharyngeal carcinoma patients and no statistically significant difference was demonstrated (HR = 1.80, 95% CI [0.56, 5.76], P = .32, Fig. 6).